138 related articles for article (PubMed ID: 11727501)
1. Gene therapy for hypertension: sense and antisense strategies.
Phillips MI
Expert Opin Biol Ther; 2001 Jul; 1(4):655-62. PubMed ID: 11727501
[TBL] [Abstract][Full Text] [Related]
2. Somatic gene therapy for hypertension.
Phillips MI
Braz J Med Biol Res; 2000 Jun; 33(6):715-21. PubMed ID: 10829100
[TBL] [Abstract][Full Text] [Related]
3. The potential role of antisense oligodeoxynucleotide therapy for cardiovascular disease.
Phillips MI; Galli SM; Mehta JL
Drugs; 2000 Aug; 60(2):239-48. PubMed ID: 10983731
[TBL] [Abstract][Full Text] [Related]
4. Chronic antisense therapy for angiotensinogen on cardiac hypertrophy in spontaneously hypertensive rats.
Makino N; Sugano M; Ohtsuka S; Sawada S; Hata T
Cardiovasc Res; 1999 Dec; 44(3):543-8. PubMed ID: 10690286
[TBL] [Abstract][Full Text] [Related]
5. Antisense inhibition and adeno-associated viral vector delivery for reducing hypertension.
Phillips MI
Hypertension; 1997 Jan; 29(1 Pt 2):177-87. PubMed ID: 9039099
[TBL] [Abstract][Full Text] [Related]
6. Intravenous angiotensinogen antisense in AAV-based vector decreases hypertension.
Tang X; Mohuczy D; Zhang YC; Kimura B; Galli SM; Phillips MI
Am J Physiol; 1999 Dec; 277(6):H2392-9. PubMed ID: 10600860
[TBL] [Abstract][Full Text] [Related]
7. Prolonged reduction of high blood pressure with an in vivo, nonpathogenic, adeno-associated viral vector delivery of AT1-R mRNA antisense.
Phillips MI; Mohuczy-Dominiak D; Coffey M; Galli SM; Kimura B; Wu P; Zelles T
Hypertension; 1997 Jan; 29(1 Pt 2):374-80. PubMed ID: 9039130
[TBL] [Abstract][Full Text] [Related]
8. Gene therapy for hypertension: antisense inhibition of the renin-angiotensin system.
Phillips MI; Kimura B
Methods Mol Med; 2005; 108():363-79. PubMed ID: 16028695
[TBL] [Abstract][Full Text] [Related]
9. Reduction of plasma angiotensin II to normal levels by antisense oligodeoxynucleotides against liver angiotensinogen cannot completely attenuate vascular remodeling in spontaneously hypertensive rats.
Sugano M; Tsuchida K; Sawada S; Makino N
J Hypertens; 2000 Jun; 18(6):725-31. PubMed ID: 10872557
[TBL] [Abstract][Full Text] [Related]
10. Attenuation of hypertension and heart hypertrophy by adeno-associated virus delivering angiotensinogen antisense.
Kimura B; Mohuczy D; Tang X; Phillips MI
Hypertension; 2001 Feb; 37(2 Pt 2):376-80. PubMed ID: 11230303
[TBL] [Abstract][Full Text] [Related]
11. Reduction of cold-induced hypertension by antisense oligodeoxynucleotides to angiotensinogen mRNA and AT1-receptor mRNA in brain and blood.
Peng JF; Kimura B; Fregly MJ; Phillips MI
Hypertension; 1998 Jun; 31(6):1317-23. PubMed ID: 9622148
[TBL] [Abstract][Full Text] [Related]
12. Prolonged attenuation of cold-induced hypertension by adenoviral delivery of renin antisense.
Wang X; Sun Z; Cade R
Kidney Int; 2005 Aug; 68(2):680-7. PubMed ID: 16014045
[TBL] [Abstract][Full Text] [Related]
13. Antisense inhibition of AT1 receptor in vascular smooth muscle cells using adeno-associated virus-based vector.
Mohuczy D; Gelband CH; Phillips MI
Hypertension; 1999 Jan; 33(1 Pt 2):354-9. PubMed ID: 9931129
[TBL] [Abstract][Full Text] [Related]
14. Recombinant adeno-associated virus-mediated delivery of antisense angiotensin II receptor 1 gene attenuates hypertension development.
Li XG; Yan JT; Xu XZ; Wang JN; Cheng LM; Wang T; Zuo P; Wang DW
Acta Pharmacol Sin; 2007 Nov; 28(11):1737-45. PubMed ID: 17959024
[TBL] [Abstract][Full Text] [Related]
15. Gene therapy for hypertension: the preclinical data.
Phillips MI
Methods Enzymol; 2002; 346():3-13. PubMed ID: 11883075
[TBL] [Abstract][Full Text] [Related]
16. Long-term inhibition of the central alpha(2B)-adrenergic receptor gene via recombinant AAV-delivered antisense in hypertensive rats.
Shenouda SM; Johns C; Kintsurashvili E; Gavras I; Gavras H
Am J Hypertens; 2006 Nov; 19(11):1135-43. PubMed ID: 17070424
[TBL] [Abstract][Full Text] [Related]
17. Antisense inhibition of AT1 receptor mRNA and angiotensinogen mRNA in the brain of spontaneously hypertensive rats reduces hypertension of neurogenic origin.
Gyurko R; Wielbo D; Phillips MI
Regul Pept; 1993 Dec; 49(2):167-74. PubMed ID: 8134617
[TBL] [Abstract][Full Text] [Related]
18. Intravenous injection with antisense oligodeoxynucleotides against angiotensinogen decreases blood pressure in spontaneously hypertensive rats.
Makino N; Sugano M; Ohtsuka S; Sawada S
Hypertension; 1998 May; 31(5):1166-70. PubMed ID: 9576130
[TBL] [Abstract][Full Text] [Related]
19. Angiotensinogen Exerts Effects Independent of Angiotensin II.
Lu H; Wu C; Howatt DA; Balakrishnan A; Moorleghen JJ; Chen X; Zhao M; Graham MJ; Mullick AE; Crooke RM; Feldman DL; Cassis LA; Vander Kooi CW; Daugherty A
Arterioscler Thromb Vasc Biol; 2016 Feb; 36(2):256-65. PubMed ID: 26681751
[TBL] [Abstract][Full Text] [Related]
20. Gene therapy to control hypertension: current studies and future perspectives.
Sellers KW; Katovich MJ; Gelband CH; Raizada MK
Am J Med Sci; 2001 Jul; 322(1):1-6. PubMed ID: 11465240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
